Rallybio Corp Financials

RLYB Stock

USD 0.74 0 0.27%

Based on the analysis of Rallybio Corp's profitability, liquidity, and operating efficiency, Rallybio Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February. At present, Rallybio Corp's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 6.5 M, whereas Other Liabilities is forecasted to decline to about 27.4 K.

Cash Flow Balance Sheet Income Statement

Covid

Rallybio Corp Balance Sheet Chart

At present, Rallybio Corp's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 6.5 M, whereas Other Liabilities is forecasted to decline to about 27.4 K.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Key indicators impacting Rallybio Corp's financial strength include:

Current Value

Last Year

Change From Last Year

10 Year Trend

Debt Equity Ratio

0.0035

0.0029

Fairly Up

Pretty Stable

Current Ratio

17.83

12.5

Significantly Up

Slightly volatile

The essential information of the day-to-day investment outlook for Rallybio Corp includes many different criteria found on its balance sheet. An individual investor should monitor Rallybio Corp's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Rallybio Corp.

Net Income

(54.6 Million)

Build AI portfolio with Rallybio Stock

Please note, the presentation of Rallybio Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Rallybio Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Rallybio Corp's management manipulating its earnings.

Rallybio Corp Stock Summary

Rallybio Corp competes with Intensity Therapeutics, Iterum Therapeutics, TAO Synergies, IBio Common, and Klotho Neurosciences. Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut. Rallybio Corporaton operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.

Specialization	Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Instrument	USA Stock View All
Exchange	NASDAQ Exchange
ISIN	US75120L1008
Business Address	234 Church Street,
Sector	Biotechnology
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.rallybio.com
Phone	203 859 3820
Currency	USD - US Dollar

Rallybio Corp Key Financial Ratios

	Return On Equity	-0.21
	Operating Margin	(32.67) %
	Price To Sales	46.26 X
	Revenue	636 K
	Gross Profit	(38.36 M)

More Fundamentals

Rallybio Corp Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	182.2M	180.4M	115.6M	68.1M	78.3M	130.1M
Other Current Liab	5.9M	9.4M	8.1M	5.0M	5.7M	6.5M
Net Debt	(175.3M)	(56.4M)	(24.1M)	(13.7M)	(15.8M)	(16.6M)
Retained Earnings	(94.0M)	(160.7M)	(235.2M)	(293.0M)	(263.7M)	(250.5M)
Accounts Payable	603K	1.1M	976K	278K	250.2K	237.7K
Cash	175.3M	57.0M	24.5M	13.9M	12.5M	11.9M
Other Current Assets	5.5M	10.5M	4.9M	2.3M	2.7M	4.7M
Total Liab	6.6M	11.1M	9.4M	6.5M	7.4M	8.1M
Net Invested Capital	175.6M	169.3M	106.2M	61.7M	70.9M	81.8M
Total Current Assets	180.9M	179.5M	114.8M	67.8M	78.0M	129.3M
Net Working Capital	174.3M	168.8M	105.5M	61.6M	70.8M	121.5M

Rallybio Corp Key Cash Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Investments	(2M)	(112.1M)	(19.9M)	33.5M	38.5M	40.4M
Change In Cash	35.1M	(118.4M)	(32.5M)	(10.6M)	(9.5M)	(9.1M)
Free Cash Flow	(45.9M)	(57.3M)	(60.3M)	(49.3M)	(44.4M)	(46.6M)
Depreciation	109K	167K	150K	131K	150.7K	118.3K
Other Non Cash Items	1.5M	640K	(1.0M)	627K	564.3K	452K
Net Income	(47.0M)	(66.7M)	(74.6M)	(57.8M)	(52.0M)	(54.6M)
End Period Cash Flow	175.3M	57.0M	24.5M	13.9M	12.5M	11.9M

Rallybio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rallybio Corp's current stock value. Our valuation model uses many indicators to compare Rallybio Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rallybio Corp competition to find correlations between indicators driving Rallybio Corp's intrinsic value. More Info.

Rallybio Corp is currently regarded as top stock in return on equity category among its peers. It is rated second in return on asset category among its peers . At present, Rallybio Corp's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rallybio Corp's earnings, one of the primary drivers of an investment's value.

Most indicators from Rallybio Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rallybio Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rallybio Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.The current year's Tax Provision is expected to grow to 1,208, whereas Selling General Administrative is forecasted to decline to about 19.2 M.

	2023	2024	2025	2026 (projected)
Interest Income	5.8M	4.2M	4.8M	5.1M
Net Interest Income	5.8M	4.2M	4.8M	5.1M

Interest Income Net Interest Income

Rallybio Corp fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Net Invested Capital	Long Term Investments	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Capital Stock	Non Currrent Assets Other
Total Assets		0.86	0.86	1.0	-0.89	0.72	0.85	-0.7	-0.56	0.04	0.69	0.26	1.0	0.5	-0.88	0.79	0.81	0.82	-0.36	0.75	1.0	1.0	-0.89	0.85	0.63	-0.57
Other Current Liab	0.86		0.99	0.85	-0.84	0.85	0.96	-0.27	-0.75	-0.11	0.26	0.11	0.85	0.69	-0.76	0.91	0.99	0.89	-0.61	0.94	0.86	0.85	-0.85	0.81	0.85	-0.86
Total Current Liabilities	0.86	0.99		0.85	-0.87	0.85	0.94	-0.26	-0.78	-0.1	0.25	0.04	0.85	0.71	-0.79	0.88	0.99	0.86	-0.67	0.95	0.86	0.85	-0.87	0.81	0.86	-0.89
Total Stockholder Equity	1.0	0.85	0.85		-0.89	0.71	0.85	-0.71	-0.55	0.04	0.7	0.27	1.0	0.49	-0.88	0.78	0.79	0.81	-0.34	0.74	1.0	1.0	-0.89	0.84	0.62	-0.56
Other Liab	-0.89	-0.84	-0.87	-0.89		-0.84	-0.72	0.48	0.83	0.21	-0.47	0.11	-0.9	-0.79	0.98	-0.63	-0.81	-0.76	0.63	-0.87	-0.89	-0.89	1.0	-0.92	-0.84	0.76
Net Tangible Assets	0.72	0.85	0.85	0.71	-0.84		0.73	-0.15	-0.92	-0.59	0.14	-0.12	0.71	0.9	-0.78	0.72	0.82	0.9	-0.62	0.94	0.72	0.71	-0.85	0.93	0.95	-0.86
Property Plant And Equipment Net	0.85	0.96	0.94	0.85	-0.72	0.73		-0.33	-0.55	0.03	0.33	0.3	0.84	0.47	-0.62	0.98	0.95	0.87	-0.45	0.83	0.85	0.85	-0.72	0.7	0.69	-0.74
Net Debt	-0.7	-0.27	-0.26	-0.71	0.48	-0.15	-0.33		-0.05	-0.34	-1.0	-0.57	-0.71	0.01	0.59	-0.29	-0.18	-0.38	-0.3	-0.13	-0.7	-0.71	0.48	-0.49	-0.01	-0.14
Retained Earnings	-0.56	-0.75	-0.78	-0.55	0.83	-0.92	-0.55	-0.05		0.59	0.07	0.44	-0.56	-0.95	0.76	-0.5	-0.74	-0.68	0.82	-0.9	-0.56	-0.55	0.83	-0.8	-0.96	0.91
Accounts Payable	0.04	-0.11	-0.1	0.04	0.21	-0.59	0.03	-0.34	0.59		0.36	0.47	0.04	-0.62	0.16	-0.05	-0.09	-0.34	0.34	-0.35	0.04	0.04	0.21	-0.42	-0.53	0.38
Cash	0.69	0.26	0.25	0.7	-0.47	0.14	0.33	-1.0	0.07	0.36		0.58	0.7	-0.03	-0.57	0.29	0.17	0.37	0.31	0.12	0.69	0.7	-0.46	0.48	0.0	0.15
Non Current Assets Total	0.26	0.11	0.04	0.27	0.11	-0.12	0.3	-0.57	0.44	0.47	0.58		0.26	-0.37	0.06	0.34	0.05	0.29	0.69	-0.09	0.26	0.27	0.11	0.05	-0.28	0.33
Cash And Short Term Investments	1.0	0.85	0.85	1.0	-0.9	0.71	0.84	-0.71	-0.56	0.04	0.7	0.26		0.5	-0.89	0.78	0.8	0.81	-0.35	0.74	1.0	1.0	-0.9	0.85	0.63	-0.56
Common Stock Shares Outstanding	0.5	0.69	0.71	0.49	-0.79	0.9	0.47	0.01	-0.95	-0.62	-0.03	-0.37	0.5		-0.74	0.44	0.67	0.69	-0.71	0.88	0.5	0.49	-0.79	0.83	0.96	-0.84
Non Current Liabilities Total	-0.88	-0.76	-0.79	-0.88	0.98	-0.78	-0.62	0.59	0.76	0.16	-0.57	0.06	-0.89	-0.74		-0.52	-0.7	-0.7	0.51	-0.77	-0.88	-0.88	0.98	-0.91	-0.75	0.63
Other Current Assets	0.79	0.91	0.88	0.78	-0.63	0.72	0.98	-0.29	-0.5	-0.05	0.29	0.34	0.78	0.44	-0.52		0.9	0.89	-0.4	0.8	0.79	0.78	-0.63	0.67	0.66	-0.71
Total Liab	0.81	0.99	0.99	0.79	-0.81	0.82	0.95	-0.18	-0.74	-0.09	0.17	0.05	0.8	0.67	-0.7	0.9		0.84	-0.67	0.94	0.81	0.79	-0.81	0.75	0.84	-0.89
Net Invested Capital	0.82	0.89	0.86	0.81	-0.76	0.9	0.87	-0.38	-0.68	-0.34	0.37	0.29	0.81	0.69	-0.7	0.89	0.84		-0.35	0.88	0.82	0.81	-0.77	0.9	0.8	-0.72
Long Term Investments	-0.36	-0.61	-0.67	-0.34	0.63	-0.62	-0.45	-0.3	0.82	0.34	0.31	0.69	-0.35	-0.71	0.51	-0.4	-0.67	-0.35		-0.72	-0.36	-0.35	0.63	-0.45	-0.78	0.89
Property Plant And Equipment Gross	0.75	0.94	0.95	0.74	-0.87	0.94	0.83	-0.13	-0.9	-0.35	0.12	-0.09	0.74	0.88	-0.77	0.8	0.94	0.88	-0.72		0.75	0.74	-0.87	0.87	0.97	-0.94
Total Current Assets	1.0	0.86	0.86	1.0	-0.89	0.72	0.85	-0.7	-0.56	0.04	0.69	0.26	1.0	0.5	-0.88	0.79	0.81	0.82	-0.36	0.75		1.0	-0.89	0.85	0.63	-0.58
Net Working Capital	1.0	0.85	0.85	1.0	-0.89	0.71	0.85	-0.71	-0.55	0.04	0.7	0.27	1.0	0.49	-0.88	0.78	0.79	0.81	-0.35	0.74	1.0		-0.89	0.84	0.62	-0.56
Common Stock	-0.89	-0.85	-0.87	-0.89	1.0	-0.85	-0.72	0.48	0.83	0.21	-0.46	0.11	-0.9	-0.79	0.98	-0.63	-0.81	-0.77	0.63	-0.87	-0.89	-0.89		-0.92	-0.84	0.76
Property Plant Equipment	0.85	0.81	0.81	0.84	-0.92	0.93	0.7	-0.49	-0.8	-0.42	0.48	0.05	0.85	0.83	-0.91	0.67	0.75	0.9	-0.45	0.87	0.85	0.84	-0.92		0.86	-0.69
Capital Stock	0.63	0.85	0.86	0.62	-0.84	0.95	0.69	-0.01	-0.96	-0.53	0.0	-0.28	0.63	0.96	-0.75	0.66	0.84	0.8	-0.78	0.97	0.63	0.62	-0.84	0.86		-0.94
Non Currrent Assets Other	-0.57	-0.86	-0.89	-0.56	0.76	-0.86	-0.74	-0.14	0.91	0.38	0.15	0.33	-0.56	-0.84	0.63	-0.71	-0.89	-0.72	0.89	-0.94	-0.58	-0.56	0.76	-0.69	-0.94

Click cells to compare fundamentals

Rallybio Corp Account Relationship Matchups

Rallybio Corp fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	182.2M	180.4M	115.6M	68.1M	78.3M	130.1M
Other Current Liab	5.9M	9.4M	8.1M	5.0M	5.7M	6.5M
Net Debt	(175.3M)	(56.4M)	(24.1M)	(13.7M)	(15.8M)	(16.6M)
Retained Earnings	(94.0M)	(160.7M)	(235.2M)	(293.0M)	(263.7M)	(250.5M)
Accounts Payable	603K	1.1M	976K	278K	250.2K	237.7K
Cash	175.3M	57.0M	24.5M	13.9M	12.5M	11.9M
Other Current Assets	5.5M	10.5M	4.9M	2.3M	2.7M	4.7M
Total Liab	6.6M	11.1M	9.4M	6.5M	7.4M	8.1M
Net Invested Capital	175.6M	169.3M	106.2M	61.7M	70.9M	81.8M
Total Current Assets	180.9M	179.5M	114.8M	67.8M	78.0M	129.3M
Net Working Capital	174.3M	168.8M	105.5M	61.6M	70.8M	121.5M

Today, most investors in Rallybio Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rallybio Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rallybio Corp growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0247

At present, Rallybio Corp's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.

Rallybio Corp January 9, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Rallybio Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rallybio Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rallybio Corp based on widely used predictive technical indicators. In general, we focus on analyzing Rallybio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rallybio Corp's daily price indicators and compare them against related drivers.

	Downside Deviation	3.8
	Information Ratio	0.0979
	Maximum Drawdown	21.25
	Value At Risk	(5.71)
	Potential Upside	7.14

Complementary Tools for Rallybio Stock analysis

When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.

	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Rallybio Corp Financials

Rallybio Corp Balance Sheet Chart

Net Income

(54.6 Million)

Rallybio Corp Stock Summary

Rallybio Corp Key Financial Ratios

Rallybio Corp Key Balance Sheet Accounts

Rallybio Corp Key Cash Accounts

Rallybio Financial Ratios Relationships

Rallybio Corp fundamental ratios Correlations

Rallybio Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rallybio Corp fundamental ratios Accounts

Price Earnings To Growth Ratio

0.0247

Rallybio Corp January 9, 2026 Opportunity Range

Complementary Tools for Rallybio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash	- 1.0	Net Debt
Capital Stock	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Non Currrent Assets Other	- 0.94	Capital Stock
Non Currrent Assets Other	- 0.94	Property Plant And Equipment Gross
Property Plant Equipment	- 0.92	Common Stock